Becoming more focused therapeutic lipid patterns: results from the Hungarian MULTI GAP 2010
Previous studies have found that many high-risk patients are not achieving their LDL-
cholesterol goals, and many patients, despite being treated with lipid-lowering therapy, also …
cholesterol goals, and many patients, despite being treated with lipid-lowering therapy, also …
Statins are less effective in common daily practice among patients with hypercholesterolemia: the REALITY-PHARMO study
WG Goettsch, DD Yin, E Alemao… - … medical research and …, 2004 - Taylor & Francis
Background: To study the use and effectiveness of lipid-lowering drugs with respect to
lowering of cholesterol levels in routine daily practice. Methods: 20 392 patients for whom …
lowering of cholesterol levels in routine daily practice. Methods: 20 392 patients for whom …
[HTML][HTML] Recommendations to improve lipid control in primary prevention patients. A consensus document of the Spanish Society of Cardiology
The reduction of low-density lipoprotein cholesterol with lipid lowering therapy has
demonstrated to decrease the risk of developing cardiovascular complications during the …
demonstrated to decrease the risk of developing cardiovascular complications during the …
Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapy
L Laforest, P Moulin, T Souchet, C Ritleng… - Atherosclerosis, 2008 - Elsevier
BACKGROUND: LDL-cholesterol therapeutic objectives attainment under lipid lowering
therapy remains inadequate. The correlates of LDL-cholesterol therapeutic objective …
therapy remains inadequate. The correlates of LDL-cholesterol therapeutic objective …
Suboptimal control of lipid levels: results from 29 countries participating in the centralized pan-regional surveys on the undertreatment of hypercholesterolaemia …
CE Chiang, J Ferrières, NN Gotcheva… - … of Atherosclerosis and …, 2016 - jstage.jst.go.jp
Aim: Five multicentre, cross-sectional Centralized Pan-Regional Surveys on the
Undertreatment of Hypercholesterolaemia (CEPHEUS) were conducted in 29 countries …
Undertreatment of Hypercholesterolaemia (CEPHEUS) were conducted in 29 countries …
Adherence to lipid-lowering guidelines for secondary prevention and potential reduction in CVD events in Swedish primary care: a cross-sectional study
H Ödesjö, S Björck, S Franzén, P Hjerpe, K Manhem… - BMJ open, 2020 - bmjopen.bmj.com
Objectives The protective effect of lipid-lowering treatment for secondary prevention after
coronary heart disease (CHD) has been well documented. Current guidelines recommend a …
coronary heart disease (CHD) has been well documented. Current guidelines recommend a …
[HTML][HTML] Assessment of lipid-lowering treatment in France–the CEPHEUS study
J Ferrières, E Tocque-Le Gousse, C Fabry… - Archives of …, 2008 - Elsevier
OBJECTIVE: Most evidence-based practice guidelines identify low-density lipoprotein
cholesterol (LDL-C) as the primary target of cholesterol-lowering therapy; the optimal LDL-C …
cholesterol (LDL-C) as the primary target of cholesterol-lowering therapy; the optimal LDL-C …